top of page

Personalizing the Pharmacotherapy Approach in First Episode Psychosis Based on Patient Need

Presented By: 

Howard C. Margolese, MDCM, MSc, FRCPC

Associate Professor, Dept. of Psychiatry, McGill University

Director, PEPP-MUHC, First Episode Psychosis Program

Learning Objectives: 

  • Discuss medication treatment approach in first episode psychosis.

  • Chose medication based on tolerability and address side effects.

  • Highlight importance of treating co-morbidities.

  • Introduce shared decision-making concepts to improve therapeutic alliance and improve medication acceptance and adherence.

Originally Presented at the 2023 Expert Speaker Series​​

This initiative has been sponsored in part by Abbvie, Janssen, and Otsuka-Lundbeck Alliance, and Teva through educational grants

Canadian Consortium for

Early Intervention in Psychosis​​

​

Hamilton, ON

905-525-8213

Contact Us: admin@epicanada.org​

  • LinkedIn
  • X

Become a Friend of EPI Canada!

© 2026, Canadian Consortium for Early Intervention in Psychosis

bottom of page